Burning Rock Biotech (BNR) Enterprise Value: 2020-2025
Historic Enterprise Value for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -$65.6 million.
- Burning Rock Biotech's Enterprise Value rose 25.21% to -$65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.6 million, marking a year-over-year increase of 25.21%. This contributed to the annual value of -$71.5 million for FY2024, which is 17.44% up from last year.
- Burning Rock Biotech's Enterprise Value amounted to -$65.6 million in Q3 2025, which was down 3.27% from -$63.5 million recorded in Q2 2025.
- Burning Rock Biotech's 5-year Enterprise Value high stood at -$63.5 million for Q2 2025, and its period low was -$331.9 million during Q2 2021.
- In the last 3 years, Burning Rock Biotech's Enterprise Value had a median value of -$85.2 million in 2024 and averaged -$85.6 million.
- In the last 5 years, Burning Rock Biotech's Enterprise Value plummeted by 2,459.43% in 2021 and then skyrocketed by 48.56% in 2023.
- Over the past 5 years, Burning Rock Biotech's Enterprise Value (MRQ) stood at -$234.6 million in 2021, then surged by 42.82% to -$134.2 million in 2022, then surged by 35.41% to -$86.7 million in 2023, then rose by 17.44% to -$71.5 million in 2024, then grew by 8.30% to -$65.6 million in 2025.
- Its Enterprise Value was -$65.6 million in Q3 2025, compared to -$63.5 million in Q2 2025 and -$68.5 million in Q1 2025.